iHateHospitals.com

CANCER NEWS: DUBLIN, Ohio — Neoprobe Corporation, a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that a multicenter Phase 3 study of Lymphoseek(R) has been initiated in patients with either breast (women’s) cancer or melanoma. The Phase 3 study will evaluate the efficacy of Lymphoseek to identify lymph [...]

CANCER NEWS: Sanofi-aventis and GEICAM (Grupo Espanol de Investigacion en Cancer de Mama) announced that for women with high-risk node-negative early stage breast (women’s) cancer adjuvant treatment (post surgery) with Taxotere(R) (docetaxel) Injection Concentrate as part of the TAC regimen (Taxotere(R), doxorubicin, cyclophosphamide) was associated with a significant improvement in Disease Free Survival (DFS) [...]

CANCER NEWS: May 14, 2008 A chemical reaction in genes that control breast (women’s) cancer provides a molecular clock that could one day help researchers more accurately determine a woman’s risk for developing breast (women’s) cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found. In a study published [...]

MEDICAL NEWS: Both the new generation of antipsychotics and the more traditional antipsychotic drugs produce an important and meaningful improvement in patients with schizophrenia, but most patients are neither cured nor free of symptoms. As a consequence, it is common to switch from one drug to another in the hope of obtaining a better [...]

MEDICAL NEWS: Background:
In clinical practice, physicians often need to change the antipsychotic medications they give to patients because of an inadequate response or the presence of unacceptable or unsafe side effects. However, there is a lack of consensus in the field as to the optimal switching strategy for antipsychotics, especially with regards to the [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … the Tucson-based non-profit institute that’s leading a drug-safety consortium. The companies still need to hammer … indicators can lead to more effective disease treatment and reduce risks patients face when taking … the UA’s poison control center. Featherstone said Vioxx a painkiller [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … than 59,000 people hope to share in drugmaker (Vioxx maker) Merck & Co.’s .85 billion settlement of … of lawsuits claiming injury from the painkiller Vioxx. Administrators have enough records to review about … plaintiffs’ attorney said an insurance company, a doctor and [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … than 59,000 people have registered claims against drugmaker (Vioxx maker) Merck & Co. for injury from painkiller Vioxx, and administrators have enough records to review … Tuesday is a more elastic deadline for medical and pharmacy records to back up claims. …

View originating article…

Vioxx [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … More than 59,000 people have registered for drug maker (Vioxx maker) Merck & Co. ’s settlement of lawsuits claiming … of lawsuits claiming injury from the painkiller Vioxx, and administrators have enough records to review …

View originating article…

National And International Report / Anheuser pegs [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … (AP) The sign outside says UCLA Medical Center but the afternoon heat and humidity … man they’ve arrested had over ,000 in drugs (don’t do drugs). LITTLE ROCK (AP) State regulators on … (Vioxx maker) Merck & Co. for injury from [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … (AP) The sign outside says UCLA Medical Center but the afternoon heat and humidity … man they’ve arrested had over ,000 in drugs (don’t do drugs). LITTLE ROCK (AP) State regulators on … (Vioxx maker) Merck & Co. for injury from [...]

VIOXX CLASS ACTION LAWSUIT UPDATE: … (AP) The sign outside says UCLA Medical Center but the afternoon heat and humidity … man they’ve arrested had over ,000 in drugs (don’t do drugs). LITTLE ROCK (AP) State regulators on … (Vioxx maker) Merck & Co. for injury from [...]